论文部分内容阅读
目的 探究每日透析在血液透析诱导期的可行性及优势性.方法 选择收治的49例慢性肾衰竭尿毒症患者作为研究对象,按入院先后分为常规透析(conventional hemodialysis,CHD)组(n=23)和每日透析(daily hemodialysis,DHD)组(n=26).CHD组患者在透析诱导期给予常规血液透析治疗,DHD组患者则在透析诱导期间给予每日透析.对比两组患者在透析前后各项临床指标变化以及失衡综合征的发生情况.结果 透析前,两组患者的各生命体征指标及各项凝血功能指标比较差异无统计学意义(P>0.05).诱导透析后,DHD组的HR、SBP以及DBP水平明显低于CHD组,其SpO2水平明显高于CHD组;两组患者仅有APTT出现明显下降,CHD组的下降幅度明显大于DHD组(P0.05).同时在诱导透析之后,DHD组的各项躯体及心理评分均明显低于CHD组(P0.05). After induction dialysis, the levels of HR, SBP and DBP in the DHD group were significantly lower than those in the CHD group, and the SpO2 level was significantly higher than that in the CHD group; Only APTT showed a marked decline in two groups, and the decrease in the CHD group was significantly greater than that in the DHD group (P0.05). After induction dialysis, the physical and psychological scores of the DHD group were significantly lower than those of the CHD group (P<0.05).Conclusion Giving patients daily hemodialysis during induction period can make the vital signs stable,incidence of imbalance syndrome significantly reduced, and to provide a more comfortable, stable and safe blood purification process to the patients, which can be used as the preferred dialysis scheme to replace conventional hemodialysis.